Irsenontrine (Synonyms: E2027) |
Catalog No.GC65911 |
Irsenontrine (E2027) es un inhibidor de la fosfodiesterasa 9 (PDE9) selectivo y activo por vÍa oral. Irsenontrine se puede utilizar para la investigaciÓn de enfermedades neurolÓgicas.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1429509-82-9
Sample solution is provided at 25 µL, 10mM.
Irsenontrine (E2027) is an orally active and selective phosphodiesterase 9 (PDE9) inhibitor. Irsenontrine can be used for the research of neurological diseases[1][2][3].
Irsenontrine (E2027) is an orally active and selective phosphodiesterase 9 (PDE 9) inhibitor[3].
Irsenontrine (0.3, 3.3 mg/kg; p.o.) exhibits a significant ameliorative effect on the percentage of exploration of the novel object at 3.3 mg/kg in Scopolamine-induced rats[1].
Irsenontrine (1 mg/kg; p.o.) and memantine hydrochloride (1 mg/kg; p.o.) combined treatment group exhibits a significantly higher percentage of exploration of the novel object than memantine hydrochloride (1 mg/kg) alone[1].
Average Rating: 5
(Based on Reviews and 30 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *